NCT04915508View on ClinicalTrials.gov

Extremely Hypofractionated Intensity Modulated Stereotactic Body Radiotherapy for the Treatment of Prostate Cancer With Rising PSA After Radical Prostatectomy

PHASE2RecruitingINTERVENTIONAL

Enrollment

102

Participants

Timeline

Start Date

June 23, 2021

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2027

Conditions

Prostate AdenocarcinomaStage IIIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIIC Prostate Cancer AJCC v8Stage IV Prostate Cancer AJCC v8Stage IVA Prostate Cancer AJCC v8Stage IVB Prostate Cancer AJCC v8

Interventions

DRUG

Hormone Therapy

Receive hormonal therapy

RADIATION

Stereotactic Body Radiation Therapy

Undergo SBRT

Trial Locations (1)

90095

RECRUITING

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

All Listed Sponsors

lead

Jonsson Comprehensive Cancer Center

OTHER